Emmessar Biotech And Nutrition (BOM:524768) Cash-to-Debt : N/A (As of Dec. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Emmessar Biotech And Nutrition Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Emmessar Biotech And Nutrition's cash to debt ratio for the quarter that ended in Dec. 2024 was N/A.

The historical rank and industry rank for Emmessar Biotech And Nutrition's Cash-to-Debt or its related term are showing as below:

BOM:524768' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.28 Med: No Debt Max: No Debt
Current: 62.97

During the past 13 years, Emmessar Biotech And Nutrition's highest Cash to Debt Ratio was No Debt. The lowest was 0.28. And the median was No Debt.

BOM:524768's Cash-to-Debt is ranked better than
86.55% of 1004 companies
in the Drug Manufacturers industry
Industry Median: 1.02 vs BOM:524768: 62.97

Emmessar Biotech And Nutrition Cash-to-Debt Historical Data

The historical data trend for Emmessar Biotech And Nutrition's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Emmessar Biotech And Nutrition Cash-to-Debt Chart

Emmessar Biotech And Nutrition Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

63.34

56.60

Emmessar Biotech And Nutrition Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Cash-to-Debt	Get a 7-Day Free Trial															N/A	56.60	N/A	No Debt	N/A

Competitive Comparison of Emmessar Biotech And Nutrition's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Emmessar Biotech And Nutrition's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Emmessar Biotech And Nutrition's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Emmessar Biotech And Nutrition's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Emmessar Biotech And Nutrition's Cash-to-Debt falls into.

Save Embed

;

Save Embed

;

Emmessar Biotech And Nutrition Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Emmessar Biotech And Nutrition's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	61.915	/	(1.094	+	0)
	=	56.60

Emmessar Biotech And Nutrition's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Emmessar Biotech And Nutrition (BOM:524768) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Emmessar Biotech And Nutrition Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Emmessar Biotech And Nutrition's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Emmessar Biotech And Nutrition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emmessar Biotech And Nutrition Ltd (BOM:524768) » Definitions » Cash-to-Debt

Traded in Other Exchanges

N/A

Address

38, Cawasji Patel Street, 29, Kamer Building, 4th floor, Fort, Mumbai, MH, IND, 400001

Website

https://www.ebnl.org

Emmessar Biotech And Nutrition Ltd is a healthcare company. The company is engaged in the manufacturing and marketing of fine chemicals products, and healthcare and nutritional products. The company caters to patients with obstinate skin problems, muscle problems, bone problems, and other debilitating chronic physical ailments. The business segments of the company are Healthcare, Fine Chemicals, and Rent on Immovable property of which the majority of the revenue is derived from the Rent on Lease land segment.

Emmessar Biotech And Nutrition Headlines

No Headlines